- Home
- ELME vs IMCR Comparison
ELME vs IMCR Comparison
Compare ELME & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELME
- IMCR
- Stock Information
- Founded
- ELME 1960
- IMCR 2008
- Country
- ELME United States
- IMCR United Kingdom
- Employees
- ELME N/A
- IMCR N/A
- Industry
- ELME Real Estate Investment Trusts
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELME Real Estate
- IMCR Health Care
- Exchange
- ELME Nasdaq
- IMCR Nasdaq
- Market Cap
- ELME 1.4B
- IMCR 1.5B
- IPO Year
- ELME N/A
- IMCR 2021
- Fundamental
- Price
- ELME $16.04
- IMCR $32.75
- Analyst Decision
- ELME Hold
- IMCR Buy
- Analyst Count
- ELME 5
- IMCR 10
- Target Price
- ELME $18.25
- IMCR $58.13
- AVG Volume (30 Days)
- ELME 630.4K
- IMCR 439.6K
- Earning Date
- ELME 07-31-2025
- IMCR 08-07-2025
- Dividend Yield
- ELME 4.52%
- IMCR N/A
- EPS Growth
- ELME N/A
- IMCR N/A
- EPS
- ELME N/A
- IMCR N/A
- Revenue
- ELME $243,915,000.00
- IMCR $333,581,000.00
- Revenue This Year
- ELME $4.84
- IMCR $26.82
- Revenue Next Year
- ELME $0.80
- IMCR $8.15
- P/E Ratio
- ELME N/A
- IMCR N/A
- Revenue Growth
- ELME 5.31
- IMCR 25.75
- 52 Week Low
- ELME $13.95
- IMCR $23.15
- 52 Week High
- ELME $18.49
- IMCR $41.54
- Technical
- Relative Strength Index (RSI)
- ELME 50.24
- IMCR 49.96
- Support Level
- ELME $15.72
- IMCR $30.76
- Resistance Level
- ELME $16.11
- IMCR $32.55
- Average True Range (ATR)
- ELME 0.30
- IMCR 1.49
- MACD
- ELME -0.02
- IMCR -0.25
- Stochastic Oscillator
- ELME 41.44
- IMCR 32.68
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.